Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach

N Engl J Med. 2020 Oct 29;383(18):1701-1703. doi: 10.1056/NEJMp2027405. Epub 2020 Aug 26.

Authors

Moncef Slaoui¹, Matthew Hepburn¹

Affiliation

¹ From Operation Warp Speed, Department of Health and Human Services, Washington, DC.

PMID: 32846056
DOI: 10.1056/NEJMp2027405

No abstract available

MeSH terms

Advisory Committees
Betacoronavirus
COVID-19
COVID-19 Vaccines
Centers for Disease Control and Prevention, U.S.
Clinical Trials as Topic
Coronavirus Infections / immunology
Coronavirus Infections / prevention & control*
Drug Approval
Drug Development* / methods
Drug Development* / organization & administration
Drug Industry
Humans
Immunization / legislation & jurisprudence
Pandemics / prevention & control*
Pneumonia, Viral / immunology
Pneumonia, Viral / prevention & control*
RNA, Viral
SARS-CoV-2
Time Factors
United States
United States Food and Drug Administration
Viral Vaccines* / immunology

Substances

COVID-19 Vaccines
RNA, Viral
Viral Vaccines